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Two new ellagic acid derivatives, named panconosides A (1) and B (2) were isolated from Pancovia
pedicellaris together with eleven known compounds (3 – 13). The structures of 1 and 2, as well as
those of the known compounds were established by spectroscopic methods and by comparison with
previously reported data. Compounds 1 and 2 were tested in vitro for their antibacterial potential
against six strains of microorganisms: Micrococcus luteus, Streptococcus ferus, Streptococcus minor,
Escherichia coli, Bacillus subtilis, and Pseudomonas agarici. They were found to exhibit moderate
antibacterial activity against all the tested strains compared to standard drugs.
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Introduction
Plants of Pancovia genus (Sapindaceae) are trees
or shrubs generally found in tropical or subtropical
regions. In Cameroon, they are used in traditional
medicine for the treatment of several ailments such
as skin diseases, dysentery and rheumatism [1]. Pre-
vious phytochemical studies on plants of this family
reported the presence of various classes of secondary
metabolites including flavonoids, coumarins, ellagic
acid, and saponins as major constituents [2 – 5]. Some
of these compounds were shown to exhibit interesting
pharmacological properties including antiplasmodial,
haemolytic and antioxidant activities [5 – 7]. Pancovia
pedicellaris Radlk & Gilg is a tree or shrub of about
5 – 10 m high, found in Central Africa [1]. No previ-
ous reports on the chemical constituents or biological
properties of this species have been reported. As part
of our ongoing search for bioactive metabolites from
Cameroonian plants, we recently investigated extracts
from the leaves and the stem bark of P. pedicellaris.
In this paper, we report the results of these investiga-
tions which led to two new ellagic acid derivatives,
panconosides A (1) and B (2), together with eleven
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known compounds identified as 3,3′,4′-tri-O-methyl-
ellagic acid 4-O-β -D-glucopyranoside (3), allantoin
(4), L-quebrachitol (5), stigmasterol (6), umbelliferone
(7), scopoletin (8), 8′-epi-cleomiscosin A (9), 3-oxo-
tirucalla-7,24-dien-21-oic acid (10), benjaminamide
(11), 3-O-β -D-glucopyranosylstigmasterol (12), and
7-oxostigmasteryl-3-O-β -D-glucopyranoside (13).
Results and Discussion
The air-dried, powdered leaves and stem bark of
P. pedicellaris were extracted separately with MeOH.
The crude extract from the leaves obtained after con-
centration was further extracted with n-hexane, and the
MeOH soluble fraction subjected to successive col-
umn chromatography over silica gel to yield five com-
pounds, including the two new ellagic acid derivatives,
i. e. the panconosides A (1) and B (2), 3,3′,4′-tri-O-
methylellagic acid 4-O-β -D-glucopyranoside (3) [8],
allantoin (4) [9], and L-quebrachitol (5) [10].
The crude MeOH extract obtained from the stem
bark was extracted with EtOAc, and the EtOAc-
soluble fraction subjected to repeated column chro-
matography over silica gel. This process yielded
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Table 1. 1H (500 MHz) and 13C NMR (125 MHz) data for 1
and 2 in [D6]DMSO.
Position 1 2












5′ 108.0 7.63 (s) 108.0 7.65 (s)
6′ 113.3 113.3
7′ 158.8 158.8
1′′ 101.3 5.40 (d, J = 8.2) 99.0 5.46 (d, J = 7.5)
2′′ 72.0 3.63 (m) 76.7 3.63 (m)
3′′ 78.0 5.17 (t, J = 9.4) 77.5 3.46 (m)
4′′ 67.9 3.55 (m) 70.1 3.24 (t, J = 8.8)
5′′ 77.4 3.65 (br s) 77.7 3.56 (br t, J = 8.8)
6′′a 60.6 3.73 (dd, J = 11.3; 5.1) 60.8 3.65 (m)
6′′b 3.57 (m) 3.48 (m)
1′′′ 120.4 100.7 5.26 (d, J = 1.3)
2′′′ 109.3 7.04 (s) 70.9 3.37 (br s)
3′′′ 145.9 70.8 3.72 (m)
4′′′ 138.6 72.3 3.18 (t, J = 9.4)
5′′′ 145.9 69.0 3.70 (m)
6′′′ 109.3 7.04 (s) 18.5 1.11 (d, J = 6.3)
7′′′ 165.9
3-OMe 62.2 4.10 (s) 62.2 4.11 (s)
3′-OMe 61.8 4.06 (s) 61.8 4.05 (s)
4′-OMe 57.2 4.01 (s) 57.2 4.01 (s)
the known compounds stigmasterol (6) [11], um-
belliferone (7) [12], scopoletin (8) [13], 8′-epi-
cleomiscosin A (9) [14], 3-oxotirucalla-7,24-dien-
21-oic acid (10) [15], benjaminamide (11) [16], 3-
O-β -D-glucopyranosylstigmasterol (12) [11], and 7-
oxostigmasteryl-3-O-β -D-glucopyranoside (13) [17].
The known compounds 3 – 13 were identified by anal-
ysis of their MS, 1H and 13C NMR data as well as by
comparison with previously reported data and authen-
tic samples.
Compound 1 was obtained as beige crystals and
gave a positive reaction with ferric chloride, indicat-
ing its phenolic nature. It also responded positively
to the Molish test, suggesting that it was a glyco-
side. Its elemental composition C30H26O17, with 18
degrees of unsaturation, was deduced from its HRMS
((+)-ESI) which exhibited a pseudo-molecular ion
peak [M+Na]+ at m/z = 681.10664 (calculated m/z =
681.10991). Its UV spectrum (λmax = 255, 280 and
355 nm) was similar to that of ellagic acid deriva-
Fig. 1. Selected HMBC (→) and NOESY (↔) correlations
in compound 1.
tives, suggesting that this compound has an ellagic acid
skeleton [18, 19]. The IR spectrum displayed charac-
teristic absorptions for hydroxy groups (3420 cm−1),
lactone functions (1748 cm−1), aromatic C=C groups
(1611 cm−1), and glycosidic C–O bonds (1085 cm−1).
The broad band-decoupled 13C NMR spectrum (Ta-
ble 1) of compound 1 displayed only 28 carbon signals
which were sorted by DEPT and HSQC techniques
into eight methines including three aromatic methine
carbons and five oxymethine carbons, one oxymethy-
lene, fifteen quaternary aromatic carbons including two
carbonyls of α , β -unsaturated lactone groups at δ =
158.6 and 158.8 [8], one ester carbonyl group at δ =
165.9 and three methoxy carbons at δ = 57.2, 61.8, and
62.2, respectively. The fact that only 28 carbon signals
were observed in the 13C NMR spectrum of 1 com-
pared to the 30 carbons of the molecular formula was
very significant and suggested that it possessed a unit
of symmetry. The 1H and 13C NMR spectra (Table 1)
also indicated the presence of a sugar residue. The sig-
nals at δ = 101.3, 78.0, 77.4, 72.0, 67.9, and 60.6 in
the 13C NMR spectrum suggested that the sugar moi-
ety in 1 was a glucopyranoside [8]. The coupling con-
stant between the anomeric protons H-1′′ [δ = 5.40 (d,
J = 8.2 Hz)] and H-2′′ [δ = 3.63 (m)] corresponded to
two trans diaxial protons, suggesting a chair confor-
mation of the carbohydrate moiety with the C-1′′ and
C-2′′ substituents in equatorial position and indicating
the presence of a β -glucoside. Its 1H NMR spectrum
(Table 1) showed also four aromatic protons as sin-
glets at δ = 7.90 (s, H-5), 7.63 (s, H-5′), and 7.04 (s,
H-2′′/H-6′′) and three methoxy groups (δ = 4.01, 4.06
and 4.10). The 28 carbon signals observed in the 13C
NMR of compound 1 include, besides glucopyranosyl
and methoxy carbons, those for the two 7-carbon units
of an ellagic acid skeleton and those for another highly
oxygenated phenyl ring attributed to a gallic acid moi-
ety with the carbonyl group at δ = 165.9 [20]. The
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ellagic acid moiety was confirmed by its HMBC cor-
relations, in particular those from H-5 (δ = 7.90) to
C-3, C-4, C-6 and C-7 and from H-5′ (δ = 7.63) to
C-3′, C-4′, C-6′ and C-7′. The location of the methoxy
groups at C-3′, C-4′ and C-3 of the ellagic acid skele-
ton was also deduced from correlations observed be-
tween the methoxy protons at δ = 4.01 (OMe-4′), 4.06
(OMe-3′) and 4.10 (OMe-3) and C-4′ (δ = 154.8), C-3′
(δ = 141.3) and C-3 (δ = 142.2), respectively. The
presence of the gallic acid moiety was confirmed by
the two-proton singlet signal observed at δ = 7.04 in-
dicating a 3, 4, 5-trihydroxy substitution pattern in one
of the aromatic rings in 1. The aromatic methine H-2′′′
(δ = 7.04) showed no HMBC correlations with the el-
lagic acid skeleton, but with C-1′′′, C-3′′′, C-4′′′ and
C-7′′′, supporting the existence of the gallic acid unit.
To establish the connectivity between the ellagic acid
moiety and the glucose on one hand and between the
sugar and the gallic acid moiety on the other hand,
use was made of observed HMBC correlations in com-
pound 1 (Fig. 1). The correlation observed from the
anomeric proton H-1′′ (δ = 5.40) to C-4 (δ = 152.1)
clearly indicates that the glucose unit was linked to C-4
of the aglycon (ellagic acid skeleton). Those from the
proton H-3′′ (δ = 5.17) of the glucose moiety to C-7′′′
(δ = 165.9, carbonyl group), C-2′′ (δ = 72.0) and C-4′′
(δ = 67.9) suggest that the galloyl unit was linked to
the glucose moiety across C-3′′ (δ = 78.0). Addition-
ally, the location of the glucose substituent was further
confirmed by the observation of an NOE between the
anomeric proton H-1′′ (δ = 5.40) and H-5 (δ = 7.90)
in the NOESY spectrum. Thus compound 1 was de-
termined as 3,3′,4′-tri-O-methylellagic acid 4-O-(3′′-
galloyl)-β -D-glucopyranoside, named panconoside A.
Compound 2 was obtained as yellow crystals. Its
molecular formula C29H32O17 was determined from
HRMS ((+)-ESI) which showed the pseudo-molecular
ion peak at m/z = 675.15354 [M+Na]+ (calculated
m/z = 675.15686) corresponding to 14 degrees of
unsaturation. It responded positively to the Molish
test, suggesting its glycoside nature. Its UV spectrum
(λmax = 255, 360 nm) was similar to that of ellagic
acid derivatives, suggesting that compound 2 like com-
pound 1 had an ellagic acid skeleton [18, 19]. The
IR spectrum displayed characteristic absorptions for
hydroxy groups (3430 cm−1) and lactone functions
(1749 cm−1), aromatic C=C groups (1600 cm−1), and
glycosidic C–O bonds (1090 cm−1). The broad band-
decoupled 13C NMR of compound 2 showed 29 car-
bon signals which were sorted by DEPT and HSQC
experiments into twelve methine groups including two
aromatic methine carbons and ten oxymethine carbons,
one oxymethylene, twelve quaternary aromatic car-
bons, including two lactone carbons and six oxygen-
bearing carbons, and three methoxy groups as well as
one methyl group at δ = 18.5 (Table 1). The NMR
spectroscopic data of 2 were similar to those of com-
pound 1, but lacked signals for a gallic acid moiety.
Its 1H NMR spectrum exhibited in addition to signals
for an ellagic acid moiety [δ = 7.83 (s, H-5) and 7.65
(s, H-5′)], and a glucopyranosyl group, five oxygen-
bearing methine protons, along with a doublet methyl
proton signal [δ = 1.11 (d, J = 6.3 Hz)] indicating the
presence of a 6-deoxy sugar. The second sugar unit
was easily determined as rhamnose through analysis
of chemical shifts and coupling constant patterns of its
proton signals (Table 1) which were connected by a
1H-1H COSY spectrum. In addition, the set of chemi-
cal shifts observed at δ = 100.7, 70.9, 70.8, 72.3, 69.0,
and 18.5 (C-1′′′ to C-6′′′) resembled the correspond-
ing signals of substituted rhamnose glycosides [18].
The anomeric protons (H-1′′, H-1′′′) of the sugar units
were observed at δ = 5.46 (d, J = 7.5 Hz, H-1′′) and
5.26 (d, J = 1.3 Hz, H-1′′′) and attributed to glucose
and rhamnose, respectively. The values of the coupling
constants suggest the β configuration for glucose [8]
and α for rhamnose [18]. The junction between the
rhamnose and glucose and between the glucose and the
ellagic acid moiety were made using the correlations
observed in the HMBC spectrum (Fig. 2). In particular,
those observed from the anomeric protons [H-1′′ (δ =
5.46)] to C-4 (δ = 151.6) and [H-1′′′ (δ = 5.26)] to C-2′′
(δ = 76.7) indicated that the glucose was linked to the
aglycon at position C-4, and the rhamnose to glucose
at position C-2′′ (C1′′′-O-C2′′ junction), respectively. In
the NOESY experiment, the observation of an NOE
between H-5 (δ = 7.83) and H-1′′ (δ = 5.46) supported
the location of the glucose unit. Acid hydrolysis of
Fig. 2. Selected HMBC (→) and NOESY (↔) correlations
in compound 2.
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Tested MIC (µg mL−1)
compound Tested microorganisms
M. luteus E. coli P. agarici S. ferus B. subtilis S. minor
Leavesa 156.25 39.06 78.12 78.12 78.12 39.06
Stema 19.53 9.76 9.76 156.25 78.12 19.53
1 78.12 78.12 39.06 39.06 78.12 39.06
2 na 78.12 78.12 na na na
Ampicillin 0.01 nt nt 1.95 3.90 3.90
Gentamicin nt 2.44 3.90 nt nt nt
Table 2. In vitro antibacterial
activity of compounds 1, 2 and
extracts.
a = extract; na = not active; nt = not
tested.
Fig. 3. Structures of com-
pounds 1, 1a, 2 and 2a.
compound 2 gave glucose, rhamnose and 3,3′,4′-tri-O-
methylellagic acid, which were identified on TLC by
comparison with known samples of glucose and rham-
nose using n-BuOH-Me2CO-H2O (4 : 5 : 1), and NMR
data for the aglycon. The three methoxy groups at δ =
4.01 (OMe-4′), 4.05 (OMe-3′) and 4.11 (OMe-3) cor-
relate with C-4′, C-3′ and C-3 carbons of the aglycon.
Thus, the structure of 2 was established as 3, 3′,4′-
tri-O-methylellagic acid 4-O-[α-L-rhamnopyranosyl-
(1→2)]-β -D-glucopyranoside, named panconoside B.
Acetylation of compounds 1 and 2 afforded the per-
acetylated derivatives 1a and 2a (Fig. 3).
The antibacterial activity of compounds 1 and 2 was
evaluated in an antibacterial assay against 6 strains
of microorganisms, Micrococcus luteus, Streptococcus
ferus, Streptococcus minor, Escherichia coli, Bacil-
lus subtilis, and Pseudomonas agarici (Table 2), by
the agar well diffusion method [21, 22]. Compound 1
displayed a moderate antibacterial effect expressed as
minimum inhibitory concentration (MIC) against all
strains. In particular, P. agarici, S. ferus and S. mi-
nor were the most inhibited (MIC = 39.06 µg mL−1).
Compound 2 also showed moderate activity against
E. coli and P. agarici (MIC = 78.12 µg mL−1). The
methanolic extract of the leaves exhibited antibacte-
rial potency with MIC values of 39.06, 78.12 and
156.23 µg mL−1. The EtOAc extract of the stem bark
showed a remarkable antibacterial effect with the best
value of MIC against E. coli and P. agarici (MIC =
9.76 µg mL−1) close to that of gentamycin used as
standard drug (Table 2). These results provide promis-
ing baseline information for the potential use of these
crude extracts in the treatment of bacterial infections.
Although ellagic acid has already been isolated from
the Sapindaceae family [4], this is the first report
of its derivatives in this family. Despite the moder-
ate antibacterial potency of compounds 1 and 2, sev-
eral ellagic acid derivatives isolated from plants ex-
hibit antiplasmodial, cytotoxic, antioxidant, and α-
glucosidase inhibitory activities [4, 20, 23, 24]. All
these results highlight the potency of this class of sec-
ondary metabolites and suggest potential uses of plants
from the genus Pancovia in medicine.
Experimental Section
General
Melting points were determined on a Büchi-540 melting
point apparatus. UV spectra were measured on a Spectronic
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Unicam Spectrophotometer. Optical rotations were measured
in DMSO solution on a Jasco Digital Polarimeter (model
DIP-360). IR spectra were determined on a JASCO FT/IR-
410 spectrometer. HRMS ((+)-ESI) were run on a Bruker
FT-ICR: APEX III (7.0 T). 1H and 13C NMR spectra were
run on a Bruker DRX spectrometer equipped with 5 mm 1H
and 13C probes operating at 500 and 125 MHz, respectively,
with TMS as internal standard. Silica gels (Merck, 230 – 400
and 70 – 230 mesh) were used for column chromatography,
while pre-coated aluminum silica gel 60 F254 sheets were
used for TLC with different mixtures of n-hexane, EtOAc,
CH2Cl2, and MeOH as eluents; spots were visualized under
UV lamps (254 and 365 nm) or by heating after spraying with
50 % H2SO4 reagent.
Plant material
The stem bark and leaves of P. pedicellaris were collected
in April 2008 from Mount Kala in the Central Region of
the Republic of Cameroon. The plant was identified by Mr.
Nana Victor, plant taxonomist at the National Herbarium of
Cameroon, where a voucher specimen (Nr. 2741 / SRFCam)
has been deposited.
Extraction and isolation
The air-dried and powdered stem bark (2.5 kg) and leaves
(2 kg) of P. pedicellaris were extracted separately with
MeOH (5 L) at r. t. for 48 h and filtered. The filtrate was
concentrated to dryness under vacuum to give 120 g and 50 g
of crude extract, respectively.
The MeOH extract from the stem bark was extracted se-
lectively with EtOAc. The EtOAc-soluble fraction was evap-
orated to dryness under vacuum to give a dry residue (40 g)
which was then subjected to column chromatography over
silica gel (Merck, 230 – 400 mesh) and eluted with a gradient
mixture of n-hexane/EtOAc and EtOAc/MeOH of increasing
polarity. Ninety column fractions, each containing 200 mL,
were collected and combined according to their TLC pro-
files on pre-coated silica gel 60 F254 plates developed with
n-hexane/EtOAc mixtures to yield 3 fractions (F1−3). Frac-
tion F1 was subjected to CC over silica gel (Merck, 70 –
230 mesh) eluted with an n-hexane/EtOAc mixture (9.5 : 0.5
to 7 : 3). This resulted in the isolation of stigmasterol (6)
(15 mg), 3-oxotirucalla-7, 24-dien-21-oic acid (10) (16 mg)
and umbelliferone (7) (56 mg). Fraction F2 was also sub-
jected to successive CC (Merck, 70 – 230 mesh) and eluted
with a mixture of n-hexane and EtOAc (6 : 4) to give scopo-
letin (8) (903 mg) and benjaminamide (11) (32 mg). Frac-
tion F3 was eluted with an n-hexane/EtOAc mixture of in-
creasing polarity (5 : 5 to 1 : 9) to yield 8′-epi-cleomiscosin
(9) (10 mg), 3-O-β -D-glucopyranosylstigmasterol (12) (900
mg) and 7-oxostigmasteryl-3-O-β -D-glucopyranoside (13)
(11 mg).
The crude MeOH extract from the leaves was dissolved in
MeOH (500 mL) and washed with n-hexane (5× 500 mL).
After concentration, this yielded 30 g of a hexane-soluble
fraction and 17 g of a MeOH fraction. This latter fraction was
subjected to silica gel (Merck, 230 – 400 mesh) flash chro-
matography and eluted with gradient n-hexane/EtOAc and
EtOAc/MeOH mixtures in the order of increasing polarity.
Thirty-five fractions, each containing 250 mL, were collected
and combined according to their TLC profiles on pre-coated
silica gel 60 F254 plates developed with n-hexane/EtOAc and
CH2Cl2/MeOH to yield 3 main fractions (F′1−3). Fraction
F′1 was subjected to CC over silica gel (Merck, 70 – 230
mesh) and eluted with a CH2Cl2/MeOH mixture (9.8 : 0.2
to 8 : 2) to yield panconoside A (1) (15 mg) and 3,3′,4′-tri-
O-methylellagic acid 4-O-β -D-glucopyranoside (3) (80 mg).
Fraction F′2 was subjected to CC over silica gel (Merck,
70 – 230 mesh) with a CH2Cl2/MeOH mixture (9.5 : 0.5 to
8 : 2) to yield panconoside B (2) (500 mg) and allantoin (4)
(855 mg). Fraction F′3 yielded L-quebrachitol (5) (725 mg)
by column chromatography separation over silica gel using
the mixture CH2Cl2/MeOH (7 : 3).
Antibacterial assays
In vitro antibacterial activity screening of the crude ex-
tracts and of compounds 1 and 2 were determined by the
agar well diffusion method as described in previous reports
[22, 23].
Acid hydrolysis of compound 2
A solution of 7 mg of compound 2 in 10 mL MeOH/H2O
(1 : 1) mixed with 5 mL 2N HCl was refluxed at 100 ◦C for
3 h. After evaporation of the organic solvent under vacuum
and threefold extraction of the aqueous phase with EtOAc,
the aglycon was identified as 3,3′,4′-tri-O-methylellagic acid
by NMR techniques. The neutralized aqueous portion re-
sulted in the detection of glucose and rhamnose by com-
parison with standard sugar samples on TLC plates using n-
BuOH/Me2CO/H2O (4 : 5 : 1) as solvents and using (NH4)6
Mo7O24Ce(SO4)2H2SO4 reagent for visualization.
Acetylation of Panconosides A (1) and B (2)
Panconoside A (1) (4 mg) or B (2) (8 mg) was dissolved
in dry pyridine (0.5 mL), and Ac2O (1.0 mL) was added. The
mixture was stirred overnight at r. t. After the usual work-up,
filtration on a short silica gel column yielded the acetylated
derivative 1a (5 mg) or 2a (10 mg).
Panconoside A [3,3′,4′-tri-O-methylellagic acid 4-O-(3′′-
galloyl)-β -D-glucopyranoside] (1)
Beige crystals, m. p. 247 – 249 ◦C. – UV/Vis (MeOH):
λmax (lgεmax) = 255 (3.42), 280 (3.43), 355 (3.44) nm. –
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[α]20D = +66.6
◦ (c = 0.3, DMSO). – IR (KBr): νmax =
3420 (O–H), 1748 (C=O), 1611 (C=C), 1356, 1085 (C – O)
cm−1. – 1H NMR ([D6]DMSO) and 13C NMR ([D6]DMSO)
spectroscopic data, see Table 1. – MS (EI, 70 eV): m/z (%) =
344 (100), 329 (17), 286 (12). – HRMS ((+)-ESI): m/z =
681.10664 (calcd. 681.10991 for C30H26O17Na, [M+Na]+).
Panconoside B [3,3′,4′-tri-O-methylellagic acid 4-O-[α-L-
rhamnopyranosyl-(1→2)]-β -D-glucopyranoside] (2)
Yellow crystals, m. p. 257 – 259 ◦C. – UV/Vis (MeOH):
λmax (lgεmax) = 255 (3.71), 360 (2.47) nm. – [α]20D = −80.0◦
(c = 0.5, MeOH). – IR (KBr): νmax = 3430 (O–H), 1749
(C=O), 1600 (C=C), 1090 cm−1. – 1H NMR ([D6]DMSO)
and 13C NMR ([D6]DMSO) spectroscopic data, see Ta-
ble 1. – MS (EI, 70 eV): m/z (%) = 344 (100), 329 (20), 286
(17). – HRMS ((+)-ESI): m/z = 675.15354 (calcd. 675.15686
for C29H32O17Na, [M+Na]+).
Panconoside A peracetate (1a)
Yellow amorphous powder. – 1H NMR (500 MHz,
CDCl3): δ = 2.03, 2.07, 2.10, 2.21, 2.32 (6× s, 18 H,
COMe), 3.50 (br s, 1H, 5′′-H), 4.06 (s, 3H, OMe), 4.09 (m,
1H, 6′′b-H), 4.15 (s, 3H, OMe), 4.24 (s, 3H, OMe), 4.29
(m, 1H, 6′′a-H), 5.27 (d, J = 7.6 Hz, 1H, 1′′-H), 5.31 (t,
J = 9.4 Hz, 1H, 3′′-H), 5.54 (m, 1H, 4′′-H), 5.57 (m, 1H,
2′′-H), 7.73 (s, 1H, 5′-H), 7.78 (s, 2H, 2′′′/6′′′-H), 7.96 (s,
1H, 5-H). – 13C NMR (125 MHz, CDCl3): δ = 20.2, 20.6
(all COMe), 56.9 (OMe), 62.0 (2×OMe), 62.3 (C-6′′), 68.0
(C-4′′), 70.7 (C-2′′), 72.7 (C-5′′), 73.4 (C-3′′), 100.0 (C-1′′),
108.0 (C-5′), 112.5 (C-5), 112.7 (C-1), 113.0 (C-1′), 113.7
(C-6′), 115.4 (C-6), 122.6 (C-2′′′/6′′′), 126.7 (C-1′′′), 139.4
(C-4′′′), 141.4 (C-3′), 141.6 (C-2′), 141.9 (C-2), 143.3 (C-3),
143.6 (C-3′′′/5′′′), 151.5 (C-4), 154.9 (C-4′), 158.4 (C-7),
158.7 (C-7′), 163.6 (C-7′′′), 166.4 (C=O), 167.5 (C=O),
169.3 (C=O), 169.5 (C=O), 170.9 (C=O).
Panconoside B peracetate (2a)
Yellow amorphous powder. – 1H NMR (500 MHz,
CDCl3): δ = 1.15 (d, J = 6.3 Hz, 3H, 6′′′-Me), 1.98, 2.00,
2.06, 2.09, 2.13, 2.16 (6× s, 18 H, COMe), 3.89 (br t, J =
8.8 Hz, 1H, 5′′-H), 3.96 (m, 1H, 2′′-H), 4.06 (s, 3H, OMe),
4.10 (m, 1H, 6′′b-H), 4.15 (m, 1H, 5′′′-H), 4.18 (m, 1H,
6′′a-H), 4.21 (s, 1H, 2′′′-H), 4.23 (s, 3H, OMe), 4.28 (s, 3H,
OMe), 5.05 (m, 1H, 3′′′-H), 5.08 (m, 1H, 4′′-H), 5.10 (m, 1H,
3′′-H), 5.16 (d, J = 1.3 Hz, 1H, 1′′′-H), 5.30 (d, J = 7.5 Hz,
1H, 1′′-H), 5.40 (t. J = 9.4 Hz, 1H, 4′′′-H), 7.71 (s, 1H, 5′-H),
7.86 (s, 1H, 5-H). – 13C NMR (125 MHz, CDCl3): δ = 17.5
(C-6′′′), 20.6, 20.7, 20.8, 20.9 (all COMe), 56.9 (OMe), 61.9
(C-6′′), 62.0 (OMe), 62.2 (OMe), 67.2 (C-5′′′), 68.3 (C-4′′),
68.4 (C-3′′′), 70.1 (C-2′′′), 70.9 (C-4′′′), 72.4 (C-2′′), 74.2
(C-3′′), 76.4 (C-5′′), 97.7 (C-1′′), 99.3 (C-1′′′), 107.9 (C-5′),
112.2 (C-5), 112.6 (C-1), 113.1 (C-1′), 113.7 (C-6′), 115.2
(C-6), 141.2 (C-3′), 141.4 (C-2), 141.9 (C-2′), 143.3 (C-3),
150.2 (C-4), 154.8 (C-4′), 158.4 (C-7), 158.6 (C-7′), 169.7
(C=O), 169.8 (C=O), 169.9 (C=O), 170.1 (C=O), 170.2
(C=O), 170.7 (C=O).
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